Adrian Rawcliffe Net Worth & Insider Trades
Adrian Rawcliffe - Chief Executive Officer, Adaptimmune Therapeutics Plc
What is Adrian Rawcliffe's Net Worth?
The current estimated net worth of Adaptimmune Therapeutics Plc's Chief Executive Officer, Adrian Rawcliffe, is estimated to be about $1.37M . Adrian Rawcliffe owns about 3,290 units of Adaptimmune Therapeutics Plc common stock. In the last 6 years at Adaptimmune Therapeutics Plc, Adrian Rawcliffe has sold an estimated value of $1.35M worth.
What is Adrian Rawcliffe's Past Insider Trading?
Adrian Rawcliffe's largest sale order was 600,000 units , worth over $1.03M on March 22, 2018. In total, Adrian Rawcliffe has made about 23 transactions over 6 years of their time at Adaptimmune Therapeutics Plc. Adrian Rawcliffe usually trades in January, with the busiest year in 2022, 2020 and 2021. The most recent transaction was a sale order of 2,562 units , worth over $4.18K on June 27, 2022.
Adrian Rawcliffe
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Adrian Rawcliffe's Salary in 2020?
As Chief Executive Officer of Adaptimmune Therapeutics Plc, Adrian Rawcliffe has a total base salary of $574,000 . Adrian Rawcliffe received compensation valued at about $2,701,602 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of option awards of $1,715,346 , other earnings, plans or compensations of $378,840 , and other compensation of $33,416 .
What is Adrian Rawcliffe's' Mailing Address?
- Mailing address is 440 South Broad Street, Unit 1906 Philadelphia PA 19146 PA
Adaptimmune Therapeutics Plc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Adrian Rawcliffe | 2020 | $574,000 | $1,715,346 | $378,840 | $33,416 | $2,701,602 |
| Adrian Rawcliffe | 2019 | $500,481 | $1,427,399 | $177,251 | $49,912 | $2,155,042 |
| Adrian Rawcliffe | 2018 | $457,011 | $730,791 | $174,807 | $54,775 | $1,417,384 |
| Gavin Wood | 2020 | $337,065 | $990,268 | $166,847 | $73,731 | $1,567,911 |
| Helen Tayton-Martin | 2020 | $454,940 | $857,661 | $225,195 | $23,531 | $1,561,327 |
| Helen Tayton-Martin | 2019 | $435,949 | $766,900 | $137,324 | $30,491 | $1,370,664 |
| Helen Tayton-Martin | 2018 | $408,308 | $730,791 | $156,178 | $22,007 | $1,317,284 |
| William Bertrand | 2020 | $443,456 | $857,661 | $219,511 | $30,485 | $1,551,113 |
| William Bertrand | 2019 | $432,640 | $766,900 | $136,282 | $35,358 | $1,371,180 |
| William Bertrand | 2018 | $416,000 | $685,114 | $159,120 | $35,070 | $1,295,304 |
| John Lunger | 2020 | $400,000 | $857,661 | $198,000 | $31,802 | $1,487,463 |
| John Lunger | 2019 | $366,867 | $435,546 | $94,542 | $35,655 | $932,610 |
| John Lunger | 2018 | $316,958 | $602,909 | $92,948 | $35,07 | $1,047,885 |
| Michael Garone | 2020 | $217,000 | - | - | - | $217,000 |
| Michael Garone | 2019 | $206,500 | - | - | - | $206,500 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1621227/000110465921047833/tm212433-2_def14a.htm
What are Adaptimmune Therapeutics Plc's Past Insider Trades?
Adaptimmune Therapeutics Plc's most recent insider trade came on August 1, 2022 by John Lunger who sold 2,983 units worth $5.29K . In the last 6 years, insiders at Adaptimmune Therapeutics Plc have sold an estimated value of $40.15M and bought an estimated value of $526.78M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Adrian Rawcliffe, Chief Executive Officer, John Lunger, Chief Patient Supply Officer, and William Charles Bertrand, Chief Operating Officer .
Adaptimmune Therapeutics PLC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||